A significant advance in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently lost in several kinds of malignancies, https://thebookpage.com/story7448238/mini-antibodies-revive-p53-the-promising-pathway-for-tumor-treatment